<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">LEVALBUTEROL HYDROCHLORIDE</span><br/>(lev-al-bu'ter-ole)<br/><span class="topboxtradename">Xopenex, </span><span class="topboxtradename">Xopenex HFA<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">beta-adrenergic agonist (sympathomimetic)</span>; <span class="classification">bronchodilator (respiratory smooth muscle relaxant)</span><br/><b>Prototype: </b>Albuterol<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.63 mg/3 mL, 1.25 mg/3 mL inhalation solution</p>
<h1><a name="action">Actions</a></h1>
<p>An isomer of albuterol with beta<sub>2</sub>-adrenergic agonist properties, drug acts on the beta<sub>2</sub> receptors of the smooth muscles of the bronchial tree, thus resulting in bronchodilation.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Decreases airway resistance, facilitates mucous drainage, and increases vital capacity.</p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment or prevention of bronchospasm in patients with reversible obstructive airway disease.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to levalbuterol or albuterol; angioedema; pregnancy (category C); children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Cardiovascular disorders especially coronary insufficiency, cardiac arrhythmias, hypertension, QT elongation, convulsive disorders;
         diabetes mellitus, diabetic ketoacidosis; older adults; seizures, status asthmaticus, tachycardia; hypersensitivity to sympathetic
         amines; hyperthyroidism, thyrotoxicosis.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Bronchospasm</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Inhalation</span> 0.63 mg by nebulization t.i.d. every 68 h, may increase to 1.25 mg t.i.d. if needed<br/><span class="rdage">Child:</span> <span class="rdroute">Inhalation</span>
<i>611 y</i> 0.31 mg by nebulization t.i.d. every 68 h (max: 0.63 mg t.i.d.)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Inhalation</span><br/><ul>
<li>Use vials within 2 wk of opening pouch. Protect vial from light and use within one wk after removal from pouch. Use only if
            solution in vial is colorless.
         </li>
</ul>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span> Compatibility when mixed with other drugs in a nebulizer has not been established. 
      </p>
<ul>
<li>Store at 15°25° C (59°77° F) in protective foil pouch.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Allergic reactions, flu syndrome, pain. <span class="typehead">CNS:</span> Migraine, dizziness, nervousness, tremor, anxiety. <span class="typehead">CV:</span> Tachycardia. <span class="typehead">GI:</span> Dyspepsia. <span class="typehead">Respiratory:</span> Increased cough, viral infection, rhinitis, sinusitis, turbinate edema, <span class="speceff-life">paradoxical bronchospasm</span>. <span class="typehead">Endocrine:</span> Increase in serum glucose. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<span class="classification">beta-adrenergic blockers</span> may antagonize <b>levalbuterol</b> effects; <span class="classification">maoi</span>, <span class="classification">tricyclic antidepressants</span> may potentiate <b>levalbuterol</b> effects on vascular system; ECG changes or hypokalemia may be exacerbated by <span class="classification">loop</span> or <span class="classification">thiazide diuretics</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> 515 min. <span class="typehead">Duration:</span> 36 h. <span class="typehead">Half-Life:</span> 3.3 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for S&amp;S of CNS or cardiovascular stimulation (e.g., BP, HR, respiratory status).</li>
<li>Lab tests: Periodic serum potassium levels especially with coadministered loop or thiazide diuretics.</li>
<li>Monitor diabetics for loss of glycemic control.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Seek medical advice immediately if a previously effective dose becomes ineffective.</li>
<li>Report immediately to physician: chest pains or palpitations, swelling of the eyelids, tongue, lips or face; increased wheezing
            or difficulty breathing.
         </li>
<li>Do not use drug more frequently than prescribed.</li>
<li>Exercise caution with hazardous activities; dizziness and vertigo are possible side effects.</li>
<li>Check with physician before taking OTC cold medication.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>